Jim Cramer Weighs In On Cano Health, Moderna And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cano Health, Inc. CANO is down around 30%. With the company having a very good management and the stock not being expensive, he recommended buying a "little more."

Regarding Ambarella, Inc. AMBA, Cramer recommended to "sell half right here."

"Honestly, look, there’s some luck involved here because the stuff that they do, I think, is a little more commodity-oriented than a lot of people believe," he said.

The "Mad Money" host said Moderna, Inc. MRNA is "very hard" for him and recommended holding the stock. He also recommended buying more Eli Lilly and Company’s LLY stock because "that’s a play on the idea that Alzheimer’s, they’ve got something."

Price Action: Shares of Cano Health dropped 7.6% to close at $9.55, while Ambarella’s stock lost 3.9% to settle at $181.33 on Monday. Moderna shares jumped 7.2%, while Eli Lilly edged lower by 0.1%.